• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒的转录后调控元件:从发现到治疗

The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy.

作者信息

Mouzannar Karim, Schauer Anne, Liang T Jake

机构信息

Liver Diseases Branch, National Institute of Diabetics and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Viruses. 2024 Mar 29;16(4):528. doi: 10.3390/v16040528.

DOI:10.3390/v16040528
PMID:38675871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055085/
Abstract

The post-transcriptional regulatory element (PRE) is present in all HBV mRNAs and plays a major role in their stability, nuclear export, and enhancement of viral gene expression. Understanding PRE's structure, function, and mode of action is essential to leverage its potential as a therapeutic target. A wide range of PRE-based reagents and tools have been developed and assessed in preclinical and clinical settings for therapeutic and biotechnology applications. This manuscript aims to provide a systematic review of the characteristics and mechanism of action of PRE, as well as elucidating its current applications in basic and clinical research. Finally, we discuss the promising opportunities that PRE may provide to antiviral development, viral biology, and potentially beyond.

摘要

转录后调控元件(PRE)存在于所有乙肝病毒(HBV)mRNA中,在其稳定性、核输出及病毒基因表达增强方面发挥主要作用。了解PRE的结构、功能及作用模式对于发挥其作为治疗靶点的潜力至关重要。已开发出多种基于PRE的试剂和工具,并在临床前和临床环境中进行了评估,以用于治疗和生物技术应用。本手稿旨在对PRE的特征和作用机制进行系统综述,并阐明其在基础研究和临床研究中的当前应用。最后,我们讨论了PRE可能为抗病毒研发、病毒生物学以及潜在的其他领域带来的有前景的机遇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a10/11055085/9fc8ef8540df/viruses-16-00528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a10/11055085/8ad3d1da199f/viruses-16-00528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a10/11055085/9fc8ef8540df/viruses-16-00528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a10/11055085/8ad3d1da199f/viruses-16-00528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a10/11055085/9fc8ef8540df/viruses-16-00528-g002.jpg

相似文献

1
The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy.乙型肝炎病毒的转录后调控元件:从发现到治疗
Viruses. 2024 Mar 29;16(4):528. doi: 10.3390/v16040528.
2
Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products.针对cccDNA的治疗干预措施:揭示作用机制并评估天然产物的效力
Front Cell Infect Microbiol. 2025 Jun 17;15:1598872. doi: 10.3389/fcimb.2025.1598872. eCollection 2025.
3
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.急性乙型肝炎感染的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2.
4
A multiplexed real-time PCR assay for simultaneous quantification of human immunodeficiency virus and Hepatitis B virus for low-and-middle- income countries.用于中低收入国家的同时定量检测人类免疫缺陷病毒和乙型肝炎病毒的多重实时 PCR 检测方法。
J Virol Methods. 2024 Dec;330:115026. doi: 10.1016/j.jviromet.2024.115026. Epub 2024 Sep 2.
5
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
6
Depalmitoylase ABHD16A negatively regulates the anti-hepatitis B virus activity of IFITM1.去棕榈酰化酶ABHD16A负向调节IFITM1的抗乙型肝炎病毒活性。
Microbiol Spectr. 2025 Jul;13(7):e0309524. doi: 10.1128/spectrum.03095-24. Epub 2025 May 28.
7
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.孕期使用乙型肝炎免疫球蛋白预防乙肝病毒母婴传播。
Cochrane Database Syst Rev. 2017 Feb 11;2(2):CD008545. doi: 10.1002/14651858.CD008545.pub2.
8
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.美国胃肠病学会关于高危个体乙型肝炎病毒再激活预防与治疗的临床实践指南。
Gastroenterology. 2025 Feb;168(2):267-284. doi: 10.1053/j.gastro.2024.11.008.
9
Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.内源性胞嘧啶脱氨酶在乙型肝炎病毒核心内对乙型肝炎病毒(HBV)基因组进行不对称修饰,为逆转录模型提供了信息。
J Virol. 2018 Apr 27;92(10). doi: 10.1128/JVI.02190-17. Print 2018 May 15.
10
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.

引用本文的文献

1
Understanding and Targeting HBV Transcription and Post-Transcriptional Regulation.理解和靶向 HBV 转录及转录后调控。
Viruses. 2024 Nov 19;16(11):1793. doi: 10.3390/v16111793.

本文引用的文献

1
Biochemical analysis of the host factor activity of ZCCHC14 in hepatitis A virus replication.ZCCHC14 宿主因子在甲型肝炎病毒复制中的生化分析。
J Virol. 2024 Apr 16;98(4):e0005724. doi: 10.1128/jvi.00057-24. Epub 2024 Mar 19.
2
Functional viromic screens uncover regulatory RNA elements.功能病毒组学筛选揭示调控 RNA 元件。
Cell. 2023 Jul 20;186(15):3291-3306.e21. doi: 10.1016/j.cell.2023.06.007. Epub 2023 Jul 5.
3
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.
慢性乙型和丁型肝炎临床治愈临床试验终点和研究设计指导:2022 年 AASLD-EASLHBV-HDV 治疗终点会议报告。
Hepatology. 2023 Nov 1;78(5):1654-1673. doi: 10.1097/HEP.0000000000000431. Epub 2023 Jun 21.
4
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.评估 RNAi 疗法 VIR-2218 和 ALN-HBV 治疗慢性乙型肝炎的效果:随机临床试验结果。
J Hepatol. 2023 Oct;79(4):924-932. doi: 10.1016/j.jhep.2023.05.023. Epub 2023 Jun 7.
5
Hepatitis B.乙型肝炎
Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9.
6
The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.ZCCHC14/TENT4 复合物是甲型肝炎病毒 RNA 合成所必需的。
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2204511119. doi: 10.1073/pnas.2204511119. Epub 2022 Jul 7.
7
Identification of dihydroquinolizinone derivatives with cyclic ether moieties as new anti-HBV agents.鉴定具有环状醚结构的二氢喹啉酮衍生物为新型抗乙肝病毒药物。
Eur J Med Chem. 2022 Aug 5;238:114518. doi: 10.1016/j.ejmech.2022.114518. Epub 2022 Jun 8.
8
Hepatitis B: a new weapon against an old enemy.乙型肝炎:对抗宿敌的新武器。
Nat Med. 2021 Oct;27(10):1672-1673. doi: 10.1038/s41591-021-01512-5.
9
Hepatoselective Dihydroquinolizinone Bis-acids for HBsAg mRNA Degradation.用于降解乙肝表面抗原信使核糖核酸的肝选择性二氢喹嗪酮双酸
ACS Med Chem Lett. 2021 Jun 22;12(7):1130-1136. doi: 10.1021/acsmedchemlett.1c00228. eCollection 2021 Jul 8.
10
Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA.宿主多聚(A)聚合酶 PAPD5 和 PAPD7 提供两层保护,确保乙型肝炎病毒 RNA 的完整性和稳定性。
J Virol. 2021 Aug 25;95(18):e0057421. doi: 10.1128/JVI.00574-21.